{"id":226506,"date":"2025-12-04T19:05:08","date_gmt":"2025-12-05T01:05:08","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/12\/glucagon-like-peptide-1-receptor-agonists-and-chronic-cough"},"modified":"2025-12-04T19:05:08","modified_gmt":"2025-12-05T01:05:08","slug":"glucagon-like-peptide-1-receptor-agonists-and-chronic-cough","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/12\/glucagon-like-peptide-1-receptor-agonists-and-chronic-cough","title":{"rendered":"Glucagon-Like Peptide-1 Receptor Agonists and Chronic Cough"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/glucagon-like-peptide-1-receptor-agonists-and-chronic-cough.png\"><\/a><\/p>\n<p>Use of glucagon-like peptide-1 receptor agonists (GLP1RA) in adults with type 2 diabetes was associated with an increased risk of new chronic cough compared with other second-line diabetes medications.<\/p>\n<hr>\n<p>Question Is the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) associated with increased risk of chronic cough?<\/p>\n<p><strong>Findings<\/strong> In this cohort study of 427 555 individuals who were prescribed a GLP-1RA and 1 614 495 matched individuals who were prescribed a different second-line diabetes medication, GLP-1RA treatment was associated with a higher adjusted hazard ratio of new chronic cough. This association was independent of gastroesophageal reflux disease diagnosis.<\/p>\n<p><strong>Meaning<\/strong> The study findings suggest that patients who use GLP-1RAs have an increased risk of chronic cough, suggesting further exploration of the strength of this association and pharmacologic mechanisms.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Use of glucagon-like peptide-1 receptor agonists (GLP1RA) in adults with type 2 diabetes was associated with an increased risk of new chronic cough compared with other second-line diabetes medications. Question Is the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) associated with increased risk of chronic cough? Findings In this cohort study of 427 555 individuals [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-226506","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/226506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=226506"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/226506\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=226506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=226506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=226506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}